{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T05:38:37Z","timestamp":1789882717143,"version":"4.0.1"},"reference-count":93,"publisher":"Wiley","issue":"4","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd012994","type":"journal-article","created":{"date-parts":[[2018,4,2]],"date-time":"2018-04-02T05:41:02Z","timestamp":1522647662000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":61,"title":["Ivermectin and permethrin for treating scabies"],"prefix":"10.1002","volume":"2018","author":[{"given":"Stefanie","family":"Rosumeck","sequence":"first","affiliation":[{"name":"Charit\u00e9 - Universit\u00e4tsmedizin Berlin, corporate member of Freie Universit\u00e4t Berlin, Humboldt-Universit\u00e4t zu Berlin, and Berlin Institute of Health; Division of Evidence Based Medicine, Department of Dermatology, Venerology and Allergology; Charit\u00e9platz 1 Berlin Berlin Germany 10117"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Nast","sequence":"additional","affiliation":[{"name":"Charit\u00e9 - Universit\u00e4tsmedizin Berlin, corporate member of Freie Universit\u00e4t Berlin, Humboldt-Universit\u00e4t zu Berlin, and Berlin Institute of Health; Division of Evidence Based Medicine, Department of Dermatology, Venerology and Allergology; Charit\u00e9platz 1 Berlin Berlin Germany 10117"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinna","family":"Dressler","sequence":"additional","affiliation":[{"name":"Charit\u00e9 - Universit\u00e4tsmedizin Berlin, corporate member of Freie Universit\u00e4t Berlin, Humboldt-Universit\u00e4t zu Berlin, and Berlin Institute of Health; Division of Evidence Based Medicine, Department of Dermatology, Venerology and Allergology; Charit\u00e9platz 1 Berlin Berlin Germany 10117"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2018,4,2]]},"reference":[{"issue":"5","key":"10.1002\/14651858.CD012994-BIB0001|cit1","doi-asserted-by":"publisher","first-page":"473","DOI":"10.3109\/09546634.2016.1151855","article-title":"Efficacy, acceptability and cost effectiveness of four therapeutic agents for treatment of scabies","volume":"27","author":"Abdel-Raheem","year":"2016","journal-title":"Journal of Dermatological Treatment"},{"issue":"1","key":"10.1002\/14651858.CD012994-BIB0002|cit2","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1111\/dth.12310","article-title":"Clinical efficacy and safety of topical versus oral ivermectin in treatment of uncomplicated scabies","volume":"29","author":"Ahmad","year":"2016","journal-title":"Dermatolologic Therapy"},{"issue":"1","key":"10.1002\/14651858.CD012994-BIB0003|cit3","doi-asserted-by":"publisher","first-page":"9","DOI":"10.4103\/0253-7613.48882","article-title":"Comparison of safety, efficacy, and cost effectiveness of benzyl benzoate, permethrin, and ivermectin in patients of scabies","volume":"41","author":"Bachewar","year":"2009","journal-title":"Indian Journal of Pharmacology"},{"issue":"5","key":"10.1002\/14651858.CD012994-BIB0004|cit4","doi-asserted-by":"publisher","first-page":"605","DOI":"10.4103\/0378-6323.100571","article-title":"Comparative efficacy and safety of topical permethrin, topical ivermectin, and oral ivermectin in patients of uncomplicated scabies","volume":"78","author":"Chhaiya","year":"2012","journal-title":"Indian Journal of Dermatology, Venereology and Leprology"},{"issue":"3","key":"10.1002\/14651858.CD012994-BIB0005|cit5","doi-asserted-by":"publisher","first-page":"186","DOI":"10.4103\/0019-5154.27981","article-title":"Evaluation of the commonest site, demographic profile and most effective therapy in scabies","volume":"51","author":"Das","year":"2006","journal-title":"Indian Journal of Dermatology"},{"issue":"3","key":"10.1002\/14651858.CD012994-BIB0006|cit6","first-page":"179","article-title":"Treatment of scabies with oral ivermectin in an enclosed rural community","volume":"40","author":"Macotela-Ruiz","year":"1996","journal-title":"Dermatologia Revista Mexicana"},{"issue":"9","key":"10.1002\/14651858.CD012994-BIB0007|cit7","doi-asserted-by":"publisher","first-page":"HC01","DOI":"10.7860\/jcdr\/2014\/9092.4878","article-title":"Comparative study of efficacy of oral ivermectin versus some topical antiscabies drugs in the treatment of scabies","volume":"8","author":"Manjhi","year":"2014","journal-title":"Journal of Clinical and Diagnostic Research"},{"issue":"2","key":"10.1002\/14651858.CD012994-BIB0008|cit8","first-page":"15","article-title":"An open label, randomized, comparative study of antiscabietic drugs permethrin, gamma benzene hexachloride and ivermectin in patients of uncomplicated scabies","volume":"3","author":"Meenakshi","year":"2014","journal-title":"International Journal of Pharmacology and Clinical Sciences"},{"issue":"4","key":"10.1002\/14651858.CD012994-BIB0009|cit9","first-page":"227","article-title":"Comparison of efficacy and safety of oral ivermectin with topical permethrin in treatment of scabies","volume":"20","author":"Mushtaq","year":"2010","journal-title":"Journal of Pakistan Association of Dermatologists"},{"key":"10.1002\/14651858.CD012994-BIB0010|cit10","first-page":"S45","article-title":"A prospective, randomized, open labelled, comparative study of efficacy and cost effectiveness of permethrin and ivermectin in 5-15 years age group patients with scabies in a tertiary care hospital","volume":"45","author":"Rohatgi","year":"2013","journal-title":"Indian Journal of Pharmacology"},{"key":"10.1002\/14651858.CD012994-BIB0011|cit11","unstructured":"Rohatgi V Doctoral thesis (as supplied 31 January 2017) Data on file"},{"issue":"1","key":"10.1002\/14651858.CD012994-BIB0012|cit12","first-page":"45","article-title":"A comparison of efficacy of single topical permethrin and single oral ivermectin in the treatment of scabies","volume":"22","author":"Saqib","year":"2012","journal-title":"Journal of Pakistan Association of Dermatologists"},{"issue":"5","key":"10.1002\/14651858.CD012994-BIB0013|cit13","doi-asserted-by":"publisher","first-page":"581","DOI":"10.4103\/0378-6323.84063","article-title":"Topical permethrin and oral ivermectin in the management of scabies: a prospective, randomized, double blind, controlled study","volume":"77","author":"Sharma","year":"2011","journal-title":"Indian Journal of Dermatology, Venereology and Leprology"},{"issue":"2 Pt 1","key":"10.1002\/14651858.CD012994-BIB0014|cit14","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/S0190-9622(00)90131-2","article-title":"A comparative study of oral ivermectin and topical permethrin cream in the treatment of scabies","volume":"42","author":"Usha","year":"2000","journal-title":"Journal of the American Academy of Dermatology"},{"key":"10.1002\/14651858.CD012994-BIB0015|cit15","first-page":"S202","article-title":"Comparison of safety, efficacy, cost effectiveness of permethrin and ivermectin in patients of scabies","volume":"45","author":"Wankhade","year":"2013","journal-title":"Indian Journal of Pharmacology"},{"issue":"5","key":"10.1002\/14651858.CD012994-BIB0016|cit16","doi-asserted-by":"publisher","first-page":"67","DOI":"10.9790\/0853-1505016772","article-title":"A comparative study of topical permethrin, oral ivermectin and combination of permethrin with ivermectin in patients of scabies","volume":"15","author":"Wankhade","year":"2016","journal-title":"IOSR Journal of Dental and Medical Sciences"},{"issue":"6","key":"10.1002\/14651858.CD012994-BIB0017|cit17","doi-asserted-by":"publisher","first-page":"799","DOI":"10.5455\/2319-2003.ijbcp20131224","article-title":"To study cost effectiveness of topical permethrin versus oral ivermectin in patients of uncomplicated scabies","volume":"2","author":"Chhaiya","year":"2013","journal-title":"International Journal of Basic & Clinical Pharmacology"},{"issue":"6","key":"10.1002\/14651858.CD012994-BIB0018|cit18","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1111\/j.1346-8138.2011.01481.x","article-title":"Treatment of scabies: comparison of permethrin 5% versus ivermectin","volume":"39","author":"Goldust","year":"2012","journal-title":"Journal of Dermatology"},{"issue":"2","key":"10.1002\/14651858.CD012994-BIB0019|cit19","first-page":"79","article-title":"Treatment of scabies: the topical ivermectin vs. permethrin 2.5% cream","volume":"59","author":"Goldust","year":"2013","journal-title":"Annals of Parasitology"},{"key":"10.1002\/14651858.CD012994-BIB0020|cit20","unstructured":"NCT02841215 Efficacy study between two different dosages of an antiparasitic in patients with crusted scabies (GALECRUSTED) clinicaltrials.gov\/ct2\/show\/NCT02841215"},{"issue":"4","key":"10.1002\/14651858.CD012994-BIB0021|cit21","first-page":"189","article-title":"The efficacy of permethrin 5% vs. oral ivermectin for the treatment of scabies","volume":"59","author":"Ranjkesh","year":"2013","journal-title":"Annals of Parasitology"},{"key":"10.1002\/14651858.CD012994-BIB0022|cit22","unstructured":"NCT02407782 Oral ivermectin versus topical permethrin to treat scabies in children (SCRATCH) clinicaltrials.gov\/show\/NCT02407782"},{"issue":"1","key":"10.1002\/14651858.CD012994-BIB0023|cit23","first-page":"95","article-title":"A report of clinical trial conducted on Toto ointment and soap products","volume":"95","author":"Alebiosu","year":"2003","journal-title":"Journal of the National Medical Association"},{"key":"10.1002\/14651858.CD012994-BIB0024|cit24","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/978-1-4471-1356-0_15","article-title":"Scabies","volume-title":"Arthropods and Human Skin","author":"Alexander","year":"1984"},{"key":"10.1002\/14651858.CD012994-BIB0025|cit25","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1146\/annurev.en.34.010189.001035","article-title":"Biology, host relations, and epidemiology of Sarcoptes scabiei","volume":"34","author":"Arlian","year":"1989","journal-title":"Annual Review of Entomology"},{"key":"10.1002\/14651858.CD012994-BIB0026|cit26","unstructured":"Therapeutic Goods Administration Australian Public Assessment Report for Ivermectin www.tga.gov.au\/auspar\/auspar-ivermectin"},{"issue":"7","key":"10.1002\/14651858.CD012994-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1093\/pch\/20.7.395","article-title":"Scabies","volume":"20","author":"Banerji","year":"2015","journal-title":"Paediatrics and Child Health"},{"issue":"4","key":"10.1002\/14651858.CD012994-BIB0028|cit28","first-page":"147","article-title":"Clinical trial on the effectiveness of Gliricidia sepium (Kakawati) in treating patients with scabies in the antipolo CBHP","volume":"28","author":"Banez","year":"1999","journal-title":"Philippine Journal of Microbiology and Infectious Diseases"},{"issue":"9059","key":"10.1002\/14651858.CD012994-BIB0029|cit29","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1016\/S0140-6736(05)63020-6","article-title":"Deaths associated with ivermectin treatment of scabies","volume":"349","author":"Barkwell","year":"1997","journal-title":"Lancet"},{"issue":"6","key":"10.1002\/14651858.CD012994-BIB0030|cit30","doi-asserted-by":"publisher","first-page":"e0179537","DOI":"10.1371\/journal.pone.0179537","article-title":"Increasing prevalence of infectious diseases in asylum seekers at a tertiary care hospital in Switzerland","volume":"12","author":"Bloch-Infanger","year":"2017","journal-title":"PLoS ONE"},{"issue":"9072","key":"10.1002\/14651858.CD012994-BIB0031|cit31","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/S0140-6736(05)62380-X","article-title":"Deaths associated with ivermectin for scabies","volume":"350","author":"Bredal","year":"1997","journal-title":"Lancet"},{"issue":"2","key":"10.1002\/14651858.CD012994-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1046\/j.1472-8206.2003.00173.x","article-title":"Current treatments for scabies","volume":"17","author":"Buffet","year":"2003","journal-title":"Fundamental & Clinical Pharmacology"},{"key":"10.1002\/14651858.CD012994-BIB0033|cit33","unstructured":"Centers for Disease Control and Prevention 2015 Sexually Transmitted Diseases Treatment Guidelines (4 August 2015) www.cdc.gov\/std\/tg2015\/ectoparasitic.htm"},{"key":"10.1002\/14651858.CD012994-BIB0034|cit34","unstructured":"Centers for Disease Control and Prevention Scabies - prevention & control (12 May 2017) www.cdc.gov\/parasites\/scabies\/prevent.html"},{"key":"10.1002\/14651858.CD012994-BIB0035|cit35","unstructured":"Centers for Disease Control and Prevention Scabies - medications (21 March 2017) www.cdc.gov\/parasites\/scabies\/health_professionals\/meds.html"},{"key":"10.1002\/14651858.CD012994-BIB0036|cit36","unstructured":"Central Drugs Standard Control Organization List of new drugs approved in India from 1991 to 2000 www.cdsco.nic.in\/writereaddata\/1991-2000.pdf"},{"issue":"9206","key":"10.1002\/14651858.CD012994-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/S0140-6736(99)09458-1","article-title":"Scabies and pediculosis","volume":"355","author":"Chosidow","year":"2000","journal-title":"Lancet"},{"issue":"1","key":"10.1002\/14651858.CD012994-BIB0038|cit38","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/j.1742-7843.2006.pto_412.x","article-title":"Number-needed-to-treat (NNT) - needs treatment with care","volume":"99","author":"Christensen","year":"2006","journal-title":"Basic & Clinical Pharmacology & Toxicology"},{"issue":"3","key":"10.1002\/14651858.CD012994-BIB0039|cit39","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1592\/phco.25.3.448.61596","article-title":"Probable topical permethrin-induced neck dystonia","volume":"25","author":"Coleman","year":"2005","journal-title":"Pharmacotherapy"},{"issue":"9072","key":"10.1002\/14651858.CD012994-BIB0040|cit40","doi-asserted-by":"publisher","first-page":"215-6; author r","DOI":"10.1016\/S0140-6736(05)62378-1","article-title":"Deaths associated with ivermectin for scabies","volume":"350","author":"Coyne","year":"1997","journal-title":"Lancet"},{"issue":"8","key":"10.1002\/14651858.CD012994-BIB0041|cit41","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1056\/NEJMct0910329","article-title":"Permethrin and ivermectin for scabies","volume":"362","author":"Currie","year":"2010","journal-title":"New England Journal of Medicine"},{"issue":"3","key":"10.1002\/14651858.CD012994-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Controlled Clinical Trials"},{"issue":"9066","key":"10.1002\/14651858.CD012994-BIB0043|cit43","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1016\/s0140-6736(05)62668-2","article-title":"Deaths after ivermectin treatment","volume":"349","author":"Diazgranados","year":"1997","journal-title":"Lancet"},{"issue":"3","key":"10.1002\/14651858.CD012994-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1017\/S0950268899002277","article-title":"The epidemiology of head lice and scabies in the UK","volume":"122","author":"Downs","year":"1999","journal-title":"Epidemiology and Infection"},{"issue":"45","key":"10.1002\/14651858.CD012994-BIB0045|cit45","doi-asserted-by":"publisher","first-page":"757","DOI":"10.3238\/arztebl.2016.0757","article-title":"The treatment of scabies","volume":"113","author":"Dressler","year":"2016","journal-title":"Deutsches \u00c4rzteblatt International"},{"issue":"2","key":"10.1002\/14651858.CD012994-BIB0046|cit46","doi-asserted-by":"publisher","first-page":"153","DOI":"10.17420\/ap6202.48","article-title":"Reporting in the clinical trials evaluating scabies treatments","volume":"62","author":"Dressler","year":"2016","journal-title":"Annals of Parasitology"},{"key":"10.1002\/14651858.CD012994-BIB0047|cit47","unstructured":"Mitchell M Engauge Digitizer 2016 10.5281\/zenodo.200196"},{"issue":"1","key":"10.1002\/14651858.CD012994-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.1365-4362.1978.tb06040.x","article-title":"Epidemiological problems of scabies","volume":"17","author":"Fain","year":"1978","journal-title":"International Journal of Dermatology"},{"issue":"6","key":"10.1002\/14651858.CD012994-BIB0049|cit49","first-page":"1089","article-title":"Ivermectin use in scabies","volume":"68","author":"Fawcett","year":"2003","journal-title":"American Family Physician"},{"key":"10.1002\/14651858.CD012994-BIB0050|cit50","unstructured":"US Food Drug Administration Drugs@FDA: FDA Approved Drug Products: Sklice (7 February 2012) www.accessdata.fda.gov\/scripts\/cder\/daf\/index.cfm?event=overview.process&applno=202736"},{"key":"10.1002\/14651858.CD012994-BIB0051|cit51","unstructured":"US Food Drug Administration Drugs@FDA: FDA Approved Drug Products: Soolantra (19 December 2014) www.accessdata.fda.gov\/scripts\/cder\/daf\/index.cfm?event=overview.process&varApplNo=206255"},{"key":"10.1002\/14651858.CD012994-BIB0052|cit52","unstructured":"McMaster University (developed by Evidence Prime Inc.) accessed 5 June 2017 GRADEpro GDT 2015"},{"key":"10.1002\/14651858.CD012994-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1093\/oxfordjournals.epirev.a036033","article-title":"Epidemiology of scabies","volume":"11","author":"Green","year":"1989","journal-title":"Epidemiologic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD012994-BIB0054|cit54","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.jclinepi.2010.07.017","article-title":"GRADE guidelines: 4. Rating the quality of evidence - study limitations (risk of bias)","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"12","key":"10.1002\/14651858.CD012994-BIB0055|cit55","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1016\/j.jclinepi.2011.01.011","article-title":"GRADE guidelines: 5. Rating the quality of evidence - publication bias","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"12","key":"10.1002\/14651858.CD012994-BIB0056|cit56","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1016\/j.jclinepi.2011.01.012","article-title":"GRADE guidelines 6. Rating the quality of evidence - imprecision","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"12","key":"10.1002\/14651858.CD012994-BIB0057|cit57","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1016\/j.jclinepi.2011.03.017","article-title":"GRADE guidelines: 7. Rating the quality of evidence - inconsistency","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"12","key":"10.1002\/14651858.CD012994-BIB0058|cit58","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1016\/j.jclinepi.2011.04.014","article-title":"GRADE guidelines: 8. Rating the quality of evidence - indirectness","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"5","key":"10.1002\/14651858.CD012994-BIB0059|cit59","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1111\/j.1610-0387.2006.05941.x","article-title":"Treatment of scabies with 5% permethrin cream: results of a German multicenter study","volume":"4","author":"Hamm","year":"2006","journal-title":"Journal der Deutschen Dermatologischen Gesellschaft [Journal of the German Society of Dermatology]"},{"key":"10.1002\/14651858.CD012994-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1468-3083.2004.00847.x","article-title":"Scabies - learning from the animals","volume":"18","author":"Hay","year":"2004","journal-title":"Journal of the European Academy of Dermatology and Venereology"},{"issue":"4","key":"10.1002\/14651858.CD012994-BIB0061|cit61","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1111\/j.1469-0691.2012.03798.x","article-title":"Scabies in the developing world - its prevalence, complications, and management","volume":"18","author":"Hay","year":"2012","journal-title":"Clinical Microbiology and Infection: the official publication of the European Society of Clinical Microbiology and Infectious Diseases"},{"issue":"2","key":"10.1002\/14651858.CD012994-BIB0062|cit62","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1097\/QCO.0b013e32835e085b","article-title":"Scabies: a suitable case for a global control initiative","volume":"26","author":"Hay","year":"2013","journal-title":"Current Opinion in Infectious Diseases"},{"key":"10.1002\/14651858.CD012994-BIB0063|cit63","unstructured":"Higgins JP Green S editor(s) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"issue":"10","key":"10.1002\/14651858.CD012994-BIB0064|cit64","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1038\/ki.2011.478","article-title":"Post-streptococcal glomerulonephritis is a strong risk factor for chronic kidney disease in later life","volume":"81","author":"Hoy","year":"2012","journal-title":"Kidney International"},{"key":"10.1002\/14651858.CD012994-BIB0065|cit65","unstructured":"InfectoPharm Arzneimittel und Consilium GmbH InfectoScab 5% Cream (September 2016) www.infectopharm.com (login required)"},{"issue":"12","key":"10.1002\/14651858.CD012994-BIB0066|cit66","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1016\/S1473-3099(17)30483-8","article-title":"The global burden of scabies: a cross-sectional analysis from the Global Burden of Disease Study 2015","volume":"17","author":"Karimkhani","year":"2017","journal-title":"Lancet Infectious Diseases"},{"issue":"5","key":"10.1002\/14651858.CD012994-BIB0067|cit67","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1007\/s00103-016-2332-9","article-title":"Infectious disease outbreaks in centralized homes for asylum seekers in Germany from 2004-2014","volume":"59","author":"K\u00fchne","year":"2016","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz [Federal Health Bulletin Health Research Health Protection]"},{"key":"10.1002\/14651858.CD012994-BIB0068|cit68","unstructured":"Lefebvre C Manheimer E Glanville J Chapter 6: Searching for studies. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD012994-BIB0069|cit69","first-page":"1347","article-title":"Infestations","volume-title":"Pediatric Dermatology","author":"Meinking","year":"1995"},{"key":"10.1002\/14651858.CD012994-BIB0070|cit70","unstructured":"Merck Sharp Dohme BV Package leaflet: Information for the user, Stromectol 3 mg, tablets (September 2015) db.cbg-meb.nl\/Bijsluiters\/h28341.pdf"},{"issue":"8","key":"10.1002\/14651858.CD012994-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1046\/j.1365-4362.1998.00491.x","article-title":"The epidemiologic trends of scabies among Israeli soldiers: a 28-year follow-up","volume":"37","author":"Mimouni","year":"1998","journal-title":"International Journal of Dermatology"},{"issue":"1","key":"10.1002\/14651858.CD012994-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1046\/j.1365-2133.2003.05329.x","article-title":"Seasonality trends of scabies in a young adult population: a 20-year follow-up","volume":"149","author":"Mimouni","year":"2003","journal-title":"British Journal of Dermatology"},{"issue":"7","key":"10.1002\/14651858.CD012994-BIB0073|cit73","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1001\/archdermatol.2009.125","article-title":"Longitudinal evidence of increasing in vitro tolerance of scabies mites to ivermectin in scabies-endemic communities","volume":"145","author":"Mounsey","year":"2009","journal-title":"Archives of Dermatology"},{"issue":"1-2","key":"10.1002\/14651858.CD012994-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0378-8741(00)00229-4","article-title":"Pediculocidal and scabicidal properties of Lippia multiflora essential oil","volume":"72","author":"Oladimeji","year":"2000","journal-title":"Journal of Ethnopharmacology"},{"issue":"2","key":"10.1002\/14651858.CD012994-BIB0075|cit75","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.ijat.2005.03.005","article-title":"A comparative study of the scabicidal activities of formulations of essential oil of Lippia multiflora Moldenke and benzyl benzoate emulsion BP","volume":"15","author":"Oladimeji","year":"2005","journal-title":"International Journal of Aromatherapy"},{"issue":"9072","key":"10.1002\/14651858.CD012994-BIB0076|cit76","doi-asserted-by":"publisher","first-page":"215; author rep","DOI":"10.1016\/S0140-6736(05)62377-X","article-title":"Deaths associated with ivermectin for scabies","volume":"350","author":"Reintjes","year":"1997","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD012994-BIB0077|cit77","unstructured":"Nordic Cochrane Centre, The Cochrane Collaboration Review Manager 5 (RevMan 5) 2014"},{"key":"10.1002\/14651858.CD012994-BIB0078|cit78","unstructured":"Robert-Koch-Institut Skabies (Kr\u00e4tze), RKI-Ratgeber f\u00fcr \u00c4rzte www.rki.de\/DE\/Content\/Infekt\/EpidBull\/Merkblaetter\/Ratgeber_Skabies.html"},{"issue":"8","key":"10.1002\/14651858.CD012994-BIB0079|cit79","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1016\/S1473-3099(15)00132-2","article-title":"Prevalence of scabies and impetigo worldwide: a systematic review","volume":"15","author":"Romani","year":"2015","journal-title":"Lancet Infectious Diseases"},{"issue":"24","key":"10.1002\/14651858.CD012994-BIB0080|cit80","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.1056\/NEJMoa1500987","article-title":"Mass drug administration for scabies control in a population with endemic disease","volume":"373","author":"Romani","year":"2015","journal-title":"New England Journal of Medicine"},{"issue":"8","key":"10.1002\/14651858.CD012994-BIB0081|cit81","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1111\/jdv.14351","article-title":"European guideline for the management of scabies","volume":"31","author":"Salavastru","year":"2017","journal-title":"Journal of the European Academy of Dermatology and Venereology: JEADV"},{"key":"10.1002\/14651858.CD012994-BIB0082|cit82","unstructured":"InfectoPharm Arzneimitel und Consilium GmbH Scabioral 3 mg Tablets (May 2016) www.infectopharm.com\/images\/newsletter\/1216\/fi-scabioral.pdf"},{"issue":"1","key":"10.1002\/14651858.CD012994-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2165\/00128071-200405010-00005","article-title":"Controlling scabies in institutional settings: a review of medications, treatment models and implementation","volume":"5","author":"Scheinfeld","year":"2004","journal-title":"American Journal of Clinical Dermatology"},{"key":"10.1002\/14651858.CD012994-BIB0084|cit84","unstructured":"Sch\u00fcnemann H Bro\u017cek J Oxman A GRADE Handbook - Handbook for grading the quality of evidence and the strength of recommendations using the GRADE approach gdt.guidelinedevelopment.org\/app\/handbook\/handbook.html"},{"issue":"11","key":"10.1002\/14651858.CD012994-BIB0085|cit85","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1111\/ddg.13130_g","article-title":"S1 guidelines on the diagnosis and treatment of scabies - short version","volume":"14","author":"Sunderk\u00f6tter","year":"2016","journal-title":"Journal der Deutschen Dermatologischen Gesellschaft [Journal of the German Society of Dermatology]"},{"issue":"7","key":"10.1002\/14651858.CD012994-BIB0086|cit86","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/j.ijpara.2004.04.002","article-title":"Genetic epidemiology of Sarcoptes scabiei (Acari: Sarcoptidae) in northern Australia","volume":"34","author":"Walton","year":"2004","journal-title":"International Journal for Parasitology"},{"key":"10.1002\/14651858.CD012994-BIB0087|cit87","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1001\/archderm.140.5.563","article-title":"Acaricidal activity of Melaleuca alternifolia (tea tree) oil","volume":"140","author":"Walton","year":"2004","journal-title":"Archives of Dermatology"},{"key":"10.1002\/14651858.CD012994-BIB0088|cit88","unstructured":"Rosumeck S Dressler C Nast A Ivermectin and permethrin for treating scabies. PROSPERO 2016:CRD42016048685 www.crd.york.ac.uk\/PROSPERO\/display_record.asp?ID=CRD42016048685"},{"issue":"3","key":"10.1002\/14651858.CD012994-BIB0089|cit89","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000320.pub2","article-title":"Interventions for treating scabies","author":"Strong","year":"2007","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD012994-BIB0090|cit90","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000320","article-title":"Drug treatment for scabies","author":"Walker","year":"1997","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD012994-BIB0091|cit91","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000320","article-title":"Interventions for treating scabies","author":"Walker","year":"1999","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD012994-BIB0092|cit92","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000320","article-title":"Interventions for treating scabies","author":"Walker","year":"1999","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD012994-BIB0093|cit93","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000320","article-title":"Interventions for treating scabies","author":"Walker","year":"2000","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD012994","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,19]],"date-time":"2022-04-19T07:28:20Z","timestamp":1650353300000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD012994"}},"subtitle":[],"editor":[{"name":"Cochrane Infectious Diseases Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,4,2]]},"references-count":93,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2018,4]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd012994","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.732961696.793582899","asserted-by":"object"}]},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,2]]}}}